These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 30075260
1. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base. Sekar A, Rudrappa S, Gopal S, Ghosal N, Gupta V, Ts L. World Neurosurg; 2018 Nov; 119():97-102. PubMed ID: 30075260 [Abstract] [Full Text] [Related]
2. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature. Inoue A, Ohnishi T, Kohno S, Nishikawa M, Nishida N, Ohue S. World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403 [Abstract] [Full Text] [Related]
3. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report. Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N. J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173 [Abstract] [Full Text] [Related]
4. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature. Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE. Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904 [Abstract] [Full Text] [Related]
5. Unresectable Clival Giant Cell Tumor, Tumor Control With Denosumab After Relapse: A Case Report and Systematic Review of the Literature. Pionelli MG, Asaftei SD, Tirtei E, Campello A, Di Rosa G, Fagioli F. J Pediatr Hematol Oncol; 2022 Jul 01; 44(5):201-209. PubMed ID: 35537059 [Abstract] [Full Text] [Related]
6. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H. Eur Spine J; 2017 May 01; 26(Suppl 1):236-242. PubMed ID: 28396950 [Abstract] [Full Text] [Related]
7. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration. Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS. World Neurosurg; 2016 Dec 01; 96():47-57. PubMed ID: 27269210 [Abstract] [Full Text] [Related]
8. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone. Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC. Orthop Surg; 2019 Dec 01; 11(6):1101-1108. PubMed ID: 31762217 [Abstract] [Full Text] [Related]
9. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA, Beltrami G, Scoccianti G, Campanacci DA, Franchi A, Capanna R. World J Surg Oncol; 2016 Nov 04; 14(1):281. PubMed ID: 27809843 [Abstract] [Full Text] [Related]
10. Surgical Management of Giant Cell Tumors in Temporomandibular Joint Region Involving Lateral Skull Base: A Multidisciplinary Approach. Shen Y, Ma C, Wang L, Li J, Wu Y, Sun J. J Oral Maxillofac Surg; 2016 Nov 04; 74(11):2295-2311. PubMed ID: 27186869 [Abstract] [Full Text] [Related]
11. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab. Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M. J Bone Joint Surg Am; 2014 Aug 06; 96(15):e127. PubMed ID: 25100780 [Abstract] [Full Text] [Related]
12. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review. Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G. Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124 [Abstract] [Full Text] [Related]
13. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases. Dubory A, Missenard G, Domont J, Court C. Spine (Phila Pa 1976); 2016 Jun 29; 41(11):E654-E660. PubMed ID: 27244112 [Abstract] [Full Text] [Related]
14. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone. Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS. Eur J Cancer; 2016 May 29; 59():1-12. PubMed ID: 26990281 [Abstract] [Full Text] [Related]
15. Is Treatment with Denosumab Associated with Local Recurrence in Patients with Giant Cell Tumor of Bone Treated with Curettage? A Systematic Review. Tsukamoto S, Tanaka Y, Mavrogenis AF, Kido A, Kawaguchi M, Errani C. Clin Orthop Relat Res; 2020 May 29; 478(5):1076-1085. PubMed ID: 31794487 [Abstract] [Full Text] [Related]
16. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab. Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E. Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393 [Abstract] [Full Text] [Related]
17. Current management of giant-cell tumor of bone in the denosumab era. Nagano A, Urakawa H, Tanaka K, Ozaki T. Jpn J Clin Oncol; 2022 May 05; 52(5):411-416. PubMed ID: 35199172 [Abstract] [Full Text] [Related]
18. Giant cell tumour of bone in the denosumab era. van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H. Eur J Cancer; 2017 May 05; 77():75-83. PubMed ID: 28365529 [Abstract] [Full Text] [Related]
19. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report. Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S. J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361 [Abstract] [Full Text] [Related]
20. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone]. Sørensen AL, Hansen RL, Jørgensen PH. Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]